MAUDE MDR 2651467

MDR report key
2651467
Report number
2243471-2012-00031
Event key
0
Event type
3
Date of event
2012-06-13
Date received
2012-07-11
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
0
Health professional
0
Initial report to FDA
0
Event location
0

Manufacturer Contact#

Contact
VINCENT STAGNITTO
Address
1080 US HWY 202S BRANCHBURG NJ 08876 US
Phone
908-908-9082
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1LIGHTCYCLER MRSA ADVANCED TEST FOR USE WITH THE LIGHTCYCLER 2.0 INSTRUMENTREAL TIME NUCLEIC ACID AMPLIFICATION SYSTEM FOR MRSAROCHE MOLECULAR SYSTEMSOOI05352894190P11990Y

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12012-07-110

Event Narratives#

N

Patient 1

(B)(4). NO PRODUCT OR BATCH NON-CONFORMANCE WAS IDENTIFIED. UPON INVESTIGATION THERE WAS NO TREND FOUND IN THE FIELD. QC RELEASE DATA FOR P11990 WAS REVIEWED AND THE ISSUE OF DISCREPANT RESULTS HAS NOT BEEN OBSERVED. THERE HAVE NOT BEEN ANY MANUFACTURING NON-CONFORMANCE REPORTS FOR BATCH P11990. RETAIN TESTING OF THE COMPLAINT BATCH P01607 WAS TESTED FOR THIS CASE AND GENERATED VALID AND ACCEPTABLE RESULTS. THE CUSTOMER RETURNED PANEL WAS SENT FOR SEQUENCING ANALYSIS. SEQUENCING ANALYSIS INDICATED THE FOLLOWING: - THE SAMPLE WAS DETERMINED TO BE SCC-MEC-RIGHT-EXTREMITY (RE) JUNCTION TYPE RE4. - THE RE4 SEQUENCE THAT WAS OBTAINED LACKS A LIGHTCYCLER (B)(6) ADVANCED TEST UPSTREAM PRIMER BINDING SITE, AND THEREFORE CANNOT BE AMPLIFIED. - THIS IS THE LIKELY CAUSE OF THE (B)(6) RESULTS FOR THIS SAMPLE BY THE (B)(6) ADVANCED TEST. THE LIGHT CYCLER (B)(6) ADVANCED TEST FOR USE WITH THE LIGHTCYCLER 2.0 INSTRUMENT PACKAGE INSERT (M/N (B)(4)) INDICATES IN THE EXTERNAL POSITIVE CONTROL (EPC) SECTION THAT "(B)(6) STRAINS REPRESENTING RIGHT EXTREMITY (RE) JUNCTION 3 AND RE7 TYPES, IF AVAILABLE MAY BE USED AS ADDITIONAL EXTERNAL POSITIVE CONTROLS TO MONITOR ASSAY PRIMERS AND PROBES NOT DIRECTLY CONTROLLED IN THE ASSAY."ALSO, THE PACKAGE INSERT INDICATES THAT "THE RE TYPES THAT HAVE BEEN SHOWN TO BE DETECTED BY THE LIGHTCYCLER (B)(6) TEST INCLUDE RE2, RE3, AND RE7." (B)(4).

D

Patient 1

A CUSTOMER IN (B)(6) FILED A COMPLAINT ALLEGING THAT A (B)(6) RESULT WAS GENERATED WHEN USING THE LIGHTCYCLER MRSA ADVANCED TEST FOR USE WITH THE LIGHTCYCLER 2.0 CE-IVD (M/N 05352894190; BATCH P11990). SPECIFICALLY, THE CUSTOMER STATED THAT THEY RAN A USER DEFINED CONTROLLED, WHICH WAS KNOWN TO CONTAIN THE (B)(6), HOWEVER, (B)(6) RESULTS WERE GENERATED WITH THE LIGHTCYCLER MRSA ADVANCED TEST FOR USE WITH THE LIGHTCYCLER 2.0 CE-IVD (M/N 05352894190; BATCH P11990).

N

Patient 1

NO CONCLUSION CAN BE DRAWN AT THIS TIME AS THE INVESTIGATION INTO THIS ISSUE IS ONGOING. THE CONCLUSION OF THE INVESTIGATION WILL BE SUBMITTED THROUGH A FOLLOW-UP REPORT. THE ASSOCIATED US PRODUCT IS M/N 05205727190, K091409. (B)(4).